Search research articles
Contact Us
Filters
Showing results (141-150 of 192) with videos related to
Page
of 20
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
April 25, 2006
Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1
Baogen Wu, Kelli Kuhen, Truc Ngoc Nguyen, et al.
Psychopharmacology
|
December 11, 2003
A high affinity ligand for GABAA-receptor containing alpha5 subunit antagonizes ethanol's neurobehavioral effects in Long-Evans rats
Peter F McKay, Katrina L Foster, Dynesha Mason, et al.
Targeted Oncology
|
April 3, 2020
Genomic Alterations and MYD88<sup>MUT</sup> Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib
Shiyu Jiang, Yan Qin, Lin Gui, et al.
Chinese Journal of Cancer
|
September 16, 2015
Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma
Yuankai Shi, Ping Zhou, Xiaohong Han, et al.
Annals of Hematology
|
October 20, 2023
Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study
Qiaofeng Zhong, Haizhu Chen, Daoguang Chen, et al.
Leukemia Research
|
October 8, 2014
The prognostic utility and the association of serum light chains (free and total) and absolute lymphocyte count in patients with newly diagnosed diffuse large B-cell lymphoma
Xiaohong Han, Jianfei Wang, Ningning Zhang, et al.
Asia-Pacific Journal of Clinical Oncology
|
August 12, 2020
R-CHOP immunochemotherapy plus surgery is associated with a superior prognosis in Chinese primary intestinal diffuse large B-cell lymphoma
Fengyi Zhao, Yan Qin, Jianliang Yang, et al.
Journal of Cancer Research and Clinical Oncology
|
April 24, 2023
MYD88<sup>L265P</sup> and MYD88<sup>other</sup> variants show different molecular characteristics and prognostic significance in diffuse large B-cell lymphoma
Yan Qin, Tian Qiu, Zucheng Xie, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 10, 2004
Identification of novel potent bicyclic peptide deformylase inhibitors
Valentina Molteni, Xiaohui He, Juliet Nabakka, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
April 19, 2019
Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China
Yuankai Shi, Ying Han, Jianliang Yang, et al.
Page
of 20
Search research articles
Search
Showing results (141-150 of 192) with videos related to
Sort By:
Page
of 20
Bioorganic & Medicinal Chemistry Letters
|
April 25, 2006
Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1
Baogen Wu, Kelli Kuhen, Truc Ngoc Nguyen, et al.
Psychopharmacology
|
December 11, 2003
A high affinity ligand for GABAA-receptor containing alpha5 subunit antagonizes ethanol's neurobehavioral effects in Long-Evans rats
Peter F McKay, Katrina L Foster, Dynesha Mason, et al.
Targeted Oncology
|
April 3, 2020
Genomic Alterations and MYD88<sup>MUT</sup> Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib
Shiyu Jiang, Yan Qin, Lin Gui, et al.
Chinese Journal of Cancer
|
September 16, 2015
Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma
Yuankai Shi, Ping Zhou, Xiaohong Han, et al.
Annals of Hematology
|
October 20, 2023
Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study
Qiaofeng Zhong, Haizhu Chen, Daoguang Chen, et al.
Leukemia Research
|
October 8, 2014
The prognostic utility and the association of serum light chains (free and total) and absolute lymphocyte count in patients with newly diagnosed diffuse large B-cell lymphoma
Xiaohong Han, Jianfei Wang, Ningning Zhang, et al.
Asia-Pacific Journal of Clinical Oncology
|
August 12, 2020
R-CHOP immunochemotherapy plus surgery is associated with a superior prognosis in Chinese primary intestinal diffuse large B-cell lymphoma
Fengyi Zhao, Yan Qin, Jianliang Yang, et al.
Journal of Cancer Research and Clinical Oncology
|
April 24, 2023
MYD88<sup>L265P</sup> and MYD88<sup>other</sup> variants show different molecular characteristics and prognostic significance in diffuse large B-cell lymphoma
Yan Qin, Tian Qiu, Zucheng Xie, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 10, 2004
Identification of novel potent bicyclic peptide deformylase inhibitors
Valentina Molteni, Xiaohui He, Juliet Nabakka, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
April 19, 2019
Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China
Yuankai Shi, Ying Han, Jianliang Yang, et al.
Page
of 20